Total Payments
$1,523
2024 Payments
$179.36
Companies
18
Transactions
60
Medicare Patients
2,115
Medicare Billing
$160,083
Payment Breakdown by Category
Food & Beverage$1,512 (99.2%)
Education$11.56 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,512 | 59 | 99.2% |
| Education | $11.56 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $337.05 | 13 | $0 (2023) |
| Lilly USA, LLC | $279.46 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $158.47 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $130.36 | 7 | $0 (2024) |
| Novo Nordisk Inc | $109.01 | 5 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $99.76 | 4 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $67.22 | 5 | $0 (2021) |
| Allergan, Inc. | $47.08 | 2 | $0 (2020) |
| PFIZER INC. | $45.89 | 2 | $0 (2022) |
| DEXCOM, INC. | $40.16 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $179.36 | 8 | Lilly USA, LLC ($93.58) |
| 2023 | $206.19 | 9 | GlaxoSmithKline, LLC. ($58.47) |
| 2022 | $395.82 | 9 | ABBVIE INC. ($193.89) |
| 2021 | $311.86 | 16 | AbbVie Inc. ($113.38) |
| 2020 | $146.13 | 7 | Allergan, Inc. ($47.08) |
| 2019 | $24.04 | 1 | AstraZeneca Pharmaceuticals LP ($24.04) |
| 2018 | $40.28 | 2 | Novo Nordisk Inc ($24.96) |
| 2017 | $219.54 | 8 | GlaxoSmithKline, LLC. ($100.00) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Gastroenterology | ||||||
| 09/24/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Respiratory | ||||||
| 04/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Diabetes | ||||||
| 03/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Oncology | ||||||
| 03/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: Respiratory | ||||||
| 11/11/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $37.67 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 05/04/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.50 | General |
| 03/13/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Obesity | ||||||
| 02/22/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: INSOMNIA | ||||||
| 02/13/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Inflammation | ||||||
| 02/02/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: INSOMNIA | ||||||
| 10/25/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.76 | General |
| Category: Diabetes | ||||||
| 10/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: PRIMARY CARE | ||||||
| 08/23/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $34.37 | General |
| Category: Neuroscience | ||||||
| 08/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.61 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 544 | 713 | $120,920 | $42,820 |
| 2022 | 5 | 510 | 693 | $113,200 | $39,245 |
| 2021 | 6 | 544 | 757 | $96,595 | $42,421 |
| 2020 | 6 | 517 | 747 | $86,150 | $35,596 |
Total Patients
2,115
Total Services
2,910
Medicare Billing
$160,083
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 263 | $65,750 | $23,468 | 35.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 165 | $33,000 | $11,358 | 34.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 25 | $7,500 | $2,955 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,000 | $2,520 | 42.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 118 | 138 | $3,450 | $1,159 | 33.6% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2023 | 51 | 54 | $1,620 | $803.40 | 49.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 45 | 48 | $3,600 | $557.04 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 179 | 256 | $64,000 | $23,025 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 153 | $30,600 | $10,488 | 34.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 34 | $10,200 | $4,600 | 45.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 162 | 207 | $5,175 | $613.47 | 11.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 40 | 43 | $3,225 | $519.40 | 16.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 187 | 262 | $48,310 | $23,492 | 48.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 110 | 189 | $29,400 | $12,748 | 43.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 28 | $6,780 | $3,628 | 53.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $2,880 | $1,304 | 45.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 161 | 213 | $5,325 | $639.00 | 12.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 47 | 52 | $3,900 | $609.96 | 15.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 170 | 242 | $38,720 | $18,803 | 48.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 126 | 234 | $32,760 | $12,300 | 37.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 22 | 23 | $4,830 | $2,531 | 52.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $2,240 | $877.48 | 39.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 151 | 199 | $4,975 | $594.18 | 11.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 34 | 35 | $2,625 | $490.63 | 18.7% |
About Dr. Dan Dardashti, M.D
Dr. Dan Dardashti, M.D is a Internal Medicine healthcare provider based in Valley Village, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275537524.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dan Dardashti, M.D has received a total of $1,523 in payments from pharmaceutical and medical device companies, with $179.36 received in 2024. These payments were reported across 60 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,512).
As a Medicare-enrolled provider, Dardashti has provided services to 2,115 Medicare beneficiaries, totaling 2,910 services with total Medicare billing of $160,083. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Valley Village, CA
- Active Since 06/01/2005
- Last Updated 07/02/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275537524
Products in Payments
- UBRELVY (Drug) $242.02
- MOUNJARO (Drug) $217.27
- INCRUSE (Drug) $100.00
- TRINTELLIX (Drug) $99.76
- QULIPTA (Drug) $74.99
- JANUVIA (Drug) $56.14
- VRAYLAR (Drug) $52.12
- Victoza (Drug) $49.51
- AIRSUPRA (Drug) $43.90
- DEXCOM G6 TRANSMITTER (Device) $40.16
- AREXVY (Drug) $37.67
- QUVIVIQ (Drug) $35.48
- EMGALITY (Drug) $34.37
- BREZTRI AEROSPHERE (Drug) $33.90
- BREZTRI (Drug) $28.52
- CHANTIX (Drug) $27.81
- Otezla (Drug) $27.11
- NURTEC ODT (Drug) $24.72
- MYDAYIS (Drug) $24.51
- SYMBICORT (Drug) $24.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Valley Village
Dr. Ara Thomassian, M.d, M.D
Internal Medicine — Payments: $4,168
Internal Medicine $4,168
Dr. Pazrica Cho, M.d, M.D
Internal Medicine — Payments: $3,263
Internal Medicine $3,263
Dr. Aron Rotman, M.d, M.D
Internal Medicine — Payments: $265.67
Internal Medicine $265.67
Soheil Gideon
Internal Medicine
Internal Medicine